Episkin / L'Oréal Research & Innovation
  • About us
  • Models & Applications

    Models

    Applications

    CMM

    • T-Skin Human Full Thickness Model
      • UV Exposure
      • Bacterial Adhesion
      • DNA Damage
      • Omics
      • Permeability
    • SkinEthic RHE Human Epidermis
      • Skin irritation
      • Skin corrosion
      • UV Exposure
      • Bacterial Adhesion
      • DNA Damage
      • Omics
      • Permeability
      • Medical Devices

    • RHE-LC Human Epidermal Model Langerhans cells
      • Skin corrosion
      • UV Exposure
      • Bacterial Adhesion
      • DNA Damage
      • Omics
      • Permeability
      • Skin Immune Response
    • EpiSkin Human Epidermis
      • Skin irritation
      • Skin corrosion
      • UV Exposure
      • Bacterial Adhesion
      • DNA Damage
      • Omics
      • Permeability
    • SkinEthic RHPE Pigmented Epidermis
      • UV Exposure
      • Omics
      • Depigmentation
    • SkinEthic HCE Corneal Epithelium
      • Bacterial Adhesion
      • Omics
      • Eye irritation

    • SkinEthic HOE Oral Epithelium
      • Oral & Gingival care
      • Bacterial Adhesion
      • Omics
    • SkinEthic HGE Gingival Epithelium
      • Oral & Gingival care
      • Bacterial Adhesion
      • Omics
    • SkinEthic HVE Vaginal Epithelium
      • Vaginal irritation
      • Bacterial Adhesion
      • Omics
  • Customer care
  • Training
  • Scientific references
  • Episkin Academy
  • Order
  • Chinese Chinese Chinese
HomeNewsEPISKIN on CNBC

EPISKIN on CNBC

Back
Reconstructed Human Epidermis

06.14.2017

  • Print

The future of alternative methods to the animal use and the key role played by EpiSkin in this revolution is explained in this brand new article by CNBC. Please discover the full article by following the link below: 

http://www.cnbc.com/2017/05/25/loreal-is-making-lab-produced-human-skin-to-curb-animal-testing.html

Episkin / L'Oréal Research & Innovation

2025 © Copyright - EPISKIN

Contact us

EPISKIN
4, rue Alexander Fleming
69366 - Lyon Cedex 7
FRANCE

Phone:
+33 4 37 28 72 00 (Switchboard)
E-mail: [email protected]

  • News
  • About us
  • Customer Care
  • Scientific references
  • FAQ
  • Contact
  • Legal Notice
  • Legal Notice
  • Privacy Policy
  • Cookie Settings